Induction of differentiation of colon cancer cells by combined inhibition of kinases and histone deacetylase

Anticancer Research

Volumn 27, Issue 2, 2007, Pages 741-748

  Lea, Michael A ^a   Ibeh, Chinwe ^b   Shah, Neel ^b   Moyer, Mary P ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Colon cancer; Differentiation; Histone acetylation; Kinase inhibitors

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 PHENYLBUTYRIC ACID; ALKALINE PHOSPHATASE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BUTYRIC ACID; ETHYL 2 MERCAPTOACETATE; ETHYLENE GLYCOL BISTHIOGLYCOLATE; GW 5074; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; PEPTIDASE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; COLON CANCER; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; BUTADIENES; CACO-2 CELLS; CELL DIFFERENTIATION; CHROMONES; COLONIC NEOPLASMS; DRUG SYNERGISM; ENZYME INDUCTION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MORPHOLINES; NITRILES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SULFHYDRYL COMPOUNDS;

EID: 34247142908     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Herz F, Schermer A, Halwer M and Bogart LH: Alkaline phosphatase in HT-29, a human colon cancer cell line: influence of sodium butyrate and hyperosmolality. Arch Biochem Biophys 210: 581-591, 1981.
2. Kim YS, Tsao D, Siddiqui B, Whitehead JS, Arnstein P, Bennett J and Hicks J: Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 45: 1185-1192, 1980.
3. Chung YS, Song IS, Erickson RH, Sleisenger MH and Kim YS: Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 45: 2976-2982, 1985.
4. Mariadason JM, Rickard KL, Barkla DH, Augenlicht LH and Gibson PR: Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J Cell Physiol 183: 347-354, 2000.
5. Witt O, Schulze S, Kanbach K, Roth C and Pekrun A: Tumor cell differentiation by butyrate and environmental stress. Cancer Lett 171: 173-182, 2001.
6. Orchel A, Dzierzewicz Z, Parfiniewicz B, Weglarz L and Wilczok T: Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent. Dig Dis Sci 50: 490-498, 2005.
7. Lea MA, Tulsyan N: Discordant effects of butyrate analogues on erythroleukemia cell proliferation and histone deacetylase. Anticancer Res 15: 879-884, 1995.
8. Lea MA and Randolph VM: Induction of reporter gene expression by inhibitors of histone deacetylase. Anticancer Res 18: 2717-2722, 1998.
9. Göttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S, Sleeman JP, Coco FL, Nervi C, Pelicci PG and Heinzel T: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed ells. EMBO J 20: 6969-6978, 2001.
10. Moyer MP, Manzano LA, Merriman RL, Stauffer JS and Tanzer LR: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol - Animal 32: 315317, 1996.
11. Lea MA, Shareef A, Sura M and desBordes C: Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules. Cancer Chemother Pharmacol 54: 57-63, 2004.
12. Nagatsu T, Hino M, Fuyamad H, Hayakawa T, Sakakibara S, Nakagawa Y and Takemoto T: New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal Biochem 74: 466-476, 1976.
13. Kojima K, Hama T, Kato T and Nagatsu T: Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxillary gland. J Chromatatog 189: 233-240, 1980.
14. Basson MD and Hong F: Tyrosine kinase inhibitors reverse butyrate stimulation of human Caco-2 intestinal epithelial cell alkaline phosphatase but not butyrate promotion of dipeptidyl dipeptidase. Cell Biol Int 22: 339-344, 1998.
15. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A and Trugnan G: Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. J Biol Chem 267: 4824-4833, 1992.
16. Ding Q, Wang Q and Evers BM: Alterations of MAPK activities associated with intestinal cell differentiation. Biochem Biophys Res Commun 284: 282-288, 2001.
17. Rahmani M, Reese E, Dai Y, Bauer C, Payne SG, Dent P, Spiegel and Grant S: Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Cancer Res 65: 2422-2432, 2005.
18. Ozaki K, Minoda A, Kishikawa F and Kohno M: Blockade of the ERK pathway markedly sensitizes tumor cells to HDAC inhibitor-induced cell death. Biochem Biophys Res Commun 339: 1171-1177, 2006.
19. Yu C, Dasmahapatra G, Dent P and Grant S: Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. Leukemia 19: 1579-1589, 2005.
20. Denlinger CE, Rundall BK and Jones DR: Inhibition of phosphatidylinositol 3-kiase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo. J Thorac Cardiovasc Surg 130: 1422-1429, 2005.
21. Wang Q, Li N, Wang X, Kim MM and Evers BM: Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3′-kinase inhibition in the KM20 human colon cancer cell line. Clin Cancer Res 8: 1940-1947, 2002.